Nanox AI (a subsidiary of Nanox)
About Nanox AI (a subsidiary of Nanox)
Nanox AI, a subsidiary of Nanox, is a healthcare AI company specializing in deep-learning medical imaging analytics. Their solutions are designed to help clinicians extract valuable and actionable clinical insights from routine medical CT scans that might otherwise go unnoticed. This approach aims to facilitate early detection and intervention, shifting healthcare from a predictive to a preventative model. Nanox AI’s offerings include solutions for cardiac health (HealthCCSng), bone health (HealthOST), and liver health (HealthFLD), which analyze CT scans for indicators of chronic conditions such as coronary artery calcification, osteoporosis, and fatty liver disease.
These AI-powered tools are intended to integrate seamlessly into existing clinical workflows, including PACS, EMR, and reporting systems, to optimize patient care and generate revenue for healthcare providers. By leveraging AI to identify incidental findings correlated with chronic conditions, Nanox AI supports proactive care management, potentially reducing hospitalizations and improving patient outcomes. The company’s technology is built upon extensive AI imaging experience, utilizing a database of over 500 million images and 30 million patient records, and has received multiple FDA clearances and CE Marks.
Focus Areas
Business Intelligence
| Technology | Cloud-native (Nanox.CLOUD), deep learning networks, medical imaging data lake, proprietary NLP for medical reports, AI-based suite of algorithms for multi-modality medical imaging |
What Physicians Need to Know
Nanox.AI's solutions empower physicians to detect incidental findings of chronic diseases like cardiovascular disease, osteoporosis, and fatty liver disease from routine CT scans, without requiring additional scan time or changes to existing workflows. This can lead to earlier intervention and improved patient outcomes. The AI-driven analysis provides quantitative and qualitative insights, such as liver density measurements and CAC scoring, which can be incorporated into radiology reports to guide clinical decision-making and preventive care recommendations. Furthermore, the integration with existing PACS and EMR systems streamlines the process, making it easy to implement and use. The ability to identify at-risk patients earlier can also help in directing them to appropriate clinical pathways and potentially increasing revenue through higher patient retention.
Nanox.AI solutions are designed for seamless integration with existing Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR) systems, ensuring minimal disruption to current workflows. They also connect with cloud-based platforms like the Nuance Precision Imaging Network, allowing for streamlined communication and AI insights within clinical workflows. The AI framework is optimized for deployment on on-premises devices using Intel's Core Ultra processors and OpenVINO toolkit, enabling analysis of CT imaging data while maintaining data privacy within the healthcare institution's infrastructure.
What the Web Says
Nanox AI, a subsidiary of Nanox, focuses on revolutionizing medical imaging through AI-powered solutions for early disease detection and preventive care. Their products analyze routine CT scans to identify asymptomatic or undiagnosed chronic conditions, aiming to improve patient outcomes and optimize healthcare resources. The company has received FDA clearance for some of its AI solutions, and its parent company, Nanox, has had its Nanox.ARC X medical imaging system recognized on TIME's Best Inventions list.
Overall: MixedStrengths
- AI-powered solutions for early disease detection and preventive care.
- FDA-cleared AI solutions for various medical conditions.
- Potential to significantly increase detection of conditions like coronary calcification and spine fractures.
- Focus on making medical imaging more accessible and affordable globally.
- Positive employee reviews regarding company culture, work-life balance, and opportunities for growth.
- Innovative technology that could disrupt the medical imaging industry.
Limitations
- Limited number of public reviews available on platforms like G2 and Capterra for Nanox AI specifically.
- Some skepticism on Reddit regarding the practical utility and widespread adoption of their core imaging technology (Nanox.ARC) in real hospitals.
- Concerns raised in the past about the transparency of their technology demonstrations and clinical study data.
- Questions about the company's path to profitability and potential need for future capital raises.
- Past issues with FDA approval delays and investor settlements for the parent company.
- Some Reddit users express concern that the technology may not completely outclass current x-ray imaging.
Based on reviews from: time.com, seekingalpha.com, stocktitan.net, indeed.com, nanox.vision, g2.com, reddit.com, auntminnie.com, secondopinions.com, youtube.com, krain.ai, capterra.com
Last updated: 2026-10-29
Videos
News, demos, and interviews about Nanox AI (a subsidiary of Nanox).
Videos load interactively. If none appear, search YouTube for Nanox AI (a subsidiary of Nanox) →
Press & Coverage
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]